Purespring Therapeutics

Developer of kidney-targeted gene therapy products intended for the treatment of chronic glomerular kidney diseases, including rare inherited and non-genetic conditions. The company offers a podocyte-...

Healthcare

London, United Kingdom

Founded 2020

50 employees

Website

Valuation

$81.6M

Market implied

Share Price

N/A

Total Raised

$164.7M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Purespring Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required